Board & Advisory

Driven by Families.
Guided by Science.

The SCN1A Gain of Function Foundation is led by a committed group of parents, advocates, and world-class researchers dedicated to rewriting the future for children with GoF mutations.

Board of Directors

👤

[Your Name]

President & Co-Founder

Driven by a personal connection to the GoF community, [Your Name] leads the foundation’s strategic vision and fundraising efforts to accelerate clinical trial readiness.

👤

[Board Member Name]

Secretary

Focused on patient advocacy and organizational transparency, ensuring our community voice remains at the center of every research grant decision.

👤

[Board Member Name]

Director of Advocacy

Leading our "Patient-to-Patient" network development to ensure symptom timelines and real-world data are captured for scientific scrutiny.

Medical Advisory Board

🔬

[Researcher Name, MD/PhD]

CHOP Epilepsy Neurogenetics Initiative (ENGIN)

A world-renowned expert in SCN1A variants and the "Philadelphia Variant," [Name] provides the foundation with critical guidance on mechanistic research and clinical protocol differentiation.

🧬

[Researcher Name, PhD]

Lead Investigator, Therapeutic Innovation

Specializing in electrophysiology and pharmacological screening, [Name] advises the board on the highest-impact seed funding opportunities for GoF-specific therapies.

Scientific Collaboration

Are you a researcher or clinician specializing in SCN1A variants or neonatal DEE? We are actively expanding our Medical Advisory Board to include diverse perspectives from the global research community.

Inquire About Advisory Roles